Ecot, Richard C.

HRN: 21-40-03  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2022
CEFTRIAXONE 1G (VIAL)
05/20/2022
05/26/2022
IV
2g
Q24
Stab Wound
Waiting Final Action 
05/29/2022
CEFTRIAXONE 1G (VIAL)
05/29/2022
06/05/2022
IV
1g
Q12
Pus Drainage On Wound
Waiting Final Action 
05/30/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/30/2022
06/06/2022
IV
600mg
Q 8H
Abscess, Ant Chest, L
Waiting Final Action 
06/01/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/01/2022
06/08/2022
IV
4.5
Q6
Infected Wound Left Chest
Waiting Final Action 
06/01/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/01/2022
06/08/2022
IV
600mg
Q6
Abscess Left Chest
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: